This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of cervix uteri
C3_CERVIX_UTERI
cervical carcinoma: A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
758 |
4. Check minimum number of eventsNone |
758 |
5. Include endpointsNone |
758 |
6. Filter based on genotype QC (FinnGen only) |
665 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of cervix uteri
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of cervix uteri, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 665 | 665 | - |
| Unadjusted period prevalence (%) | 0.24 | 0.24 | - |
| Median age at first event (years) | 42.66 | 42.66 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 704
- Matched controls
- 7040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
24.9
307.7
316
223
H02AB02
ATC
dexamethasone; systemic
68.6
307.7
191
38
ULA02
NOMESCO Finland
Kolposcopy
13.2
275.1
405
653
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
263.6
236
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
250.4
225
*
128
Kela drug reimbursment
Cancers of female genital organs
2988.9
246.9
224
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
233.8
211
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
64.6
220.4
123
23
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
10.8
203.7
288
423
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
9.5
203.5
379
769
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.7
202.4
349
649
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
184.7
169
*
XX3DW
NOMESCO Finland
Time consuming IT work
16.7
182.3
168
130
ZXC96
NOMESCO Finland
Robot assisted procedure
68.4
181.6
100
17
LEB00
NOMESCO Finland
Biopsy of vagina
29.7
170.5
117
47
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
33.3
157.0
103
36
WF002
NOMESCO Finland
Radical radiotherapy
269.3
150.5
149
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
147.2
136
*
B01AB10
ATC
tinzaparin; parenteral
8.4
129.7
203
323
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
128.1
119
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
73.9
123.5
67
10
JN4BD
NOMESCO Finland
Extensive body CT
14.9
121.7
115
91
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.6
121.1
107
75
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
12.6
119.7
127
121
A04AA01
ATC
ondansetron; systemic, rectal
11.7
119.3
134
139
LDA10
NOMESCO Finland
Curettage of cervix uteri
9.1
117.3
164
227
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
114.8
107
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
113.7
106
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
110.4
103
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
109.1
289
762
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
13.3
107.8
109
96
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
10.7
103.6
123
137
121
Kela drug reimbursment
Severe hypofunction of sexual glands
14.2
93.1
89
71
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
90.6
85
*
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
87.3
82
*
JN4AD
NOMESCO Finland
Body CT examination
9.8
85.5
107
127
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
85.2
80
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
83.0
78
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
24.2
82.7
60
27
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
304.9
81.4
81
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
78.6
74
*
Z51.5
ICD-10 Finland
Palliative care
11.9
78.1
83
78
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
76.5
72
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.6
75.9
244
727
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
73.2
69
*
A04AA02
ATC
granisetron; systemic, transdermal
396.4
73.1
72
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
70.0
66
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
70.0
66
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
17.6
68.3
57
35
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
67.8
64
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
190.9
67.3
69
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
7.9
65.6
97
140
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
238.3
64.3
65
*
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
676.5
63.9
62
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
31.0
62.0
41
14
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
628.7
59.6
58
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
59.0
351
1552
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
58.1
55
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
57.1
54
*
WW500
NOMESCO Finland
Blood transfusion
10.9
56.5
63
63
L03AA13
ATC
pegfilgrastim; parenteral
593.3
56.4
55
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
593.3
56.4
55
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
304.9
56.1
56
*
A04AD12
ATC
aprepitant; systemic
298.8
55.0
55
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
569.8
54.3
53
*
B01AB05
ATC
enoxaparin; parenteral
3.4
54.1
302
1269
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
53.8
51
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
51.7
49
*
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
51.7
49
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
49.6
47
*
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
8.5
48.4
65
83
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.2
47.4
55
58
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
46.4
44
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
46.4
44
*
C539, 8085, 3
ICD-O-3
+∞
45.3
43
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.9
44.3
57
69
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
44.2
42
*
WZC30
NOMESCO Finland
Teaching
3.9
41.6
146
446
ZX090
NOMESCO Finland
Other technic of radiotherapy
222.9
41.3
42
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
217.3
40.3
41
*
8070/3-C53.1
ICD-O-3
Squamous cell carcinoma, NOS, of exocervix
+∞
40.0
38
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
7.2
39.3
61
92
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
144.9
39.2
41
*
C53.10
ICD-10 Finland
Malignant tumor of the exocervix without histology
+∞
38.9
37
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
6.6
38.5
65
107
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
386.9
37.4
37
*
130
Kela drug reimbursment
Malignant tumour
+∞
36.8
35
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
36.8
35
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
36.6
390
2216
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
194.9
36.1
37
*
115
Kela drug reimbursment
Breast cancer
+∞
35.7
34
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
35.7
34
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
34.7
33
*
N02AA05
ATC
oxycodone; systemic
3.4
34.3
147
508
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
+∞
33.6
32
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
57.2
32.6
38
7
UKC02
NOMESCO Finland
Cystoscopy
3.7
32.5
115
350
WX402
NOMESCO Finland
General anaesthesia
2.9
32.4
205
884
WF049
NOMESCO Finland
Radiotherapy of metastasis
331.3
32.1
32
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
30.4
29
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
30.4
29
*
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
+∞
29.4
28
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.8
28.7
174
729
ZX120
NOMESCO Finland
Intravenous
4.3
28.5
79
201
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
28.3
27
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
28.3
27
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
28.1
49
83
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
27.3
26
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.1
26.5
33
38
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.8
26.4
29
28
C53.19
ICD-10 Finland
Malignant tumor of the exocervix, unspecified histology
+∞
26.2
25
*
L03AA02
ATC
filgrastim; parenteral
+∞
26.2
25
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
26.2
25
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
60.4
25.2
29
5
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
25.2
24
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
72.6
25.0
28
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
24.7
114
408
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.1
23
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
+∞
24.1
23
*
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
24.1
23
*
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
5.1
24.0
52
108
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
23.9
81
238
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
129.4
23.7
25
*
8070/3-C53.0
ICD-O-3
Squamous cell carcinoma, NOS, of endocervix
+∞
23.0
22
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
237.4
22.8
23
*
HA1AA
NOMESCO Finland
X-ray mammography
4.4
22.3
58
140
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
21.9
101
360
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
5.6
21.6
42
79
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
20.9
20
*
C53.91
ICD-10 Finland
Squamous cell carcinoma in an unspecified location in the cervix
+∞
20.9
20
*
L01BC06
ATC
capecitabine; oral
+∞
20.9
20
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
20.9
20
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
216.1
20.7
21
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
19.9
19
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
19.9
61
167
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.8
19.8
37
67
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
20.8
19.2
28
14
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
56.7
19.0
22
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
18.8
18
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
18.8
18
*
C539, 8483, 3
ICD-O-3
+∞
18.8
18
*
1801A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Exocervix
+∞
18.8
18
*
LBE10
NOMESCO Finland
Bilateral salpingectomy
45.3
18.3
22
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.1
17.9
51
132
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.8
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
C53.89
ICD-10 Finland
Overall malignant tumor of the cervix uteri, unspecified histology
+∞
17.8
17
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
17.7
51
133
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
37.8
17.7
22
6
KA1FN
NOMESCO Finland
Isotope renography
37.8
17.7
22
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
17.5
165
833
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
17.5
72
239
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
22.5
17.0
24
11
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
16.7
16
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
16.7
16
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
16.7
16
*
X75
ICPC
Malignant neoplasm cervix
+∞
16.7
16
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
92.3
16.6
18
*
JN5DS
NOMESCO Finland
PET-MRI of body metabolism
+∞
15.7
15
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
87.1
15.6
17
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.7
14.9
35
78
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
14.6
14
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
14.6
14
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
81.9
14.6
16
*
WZC15, ,
NOMESCO Finland
81.9
14.6
16
*
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
153.1
14.5
15
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
14.5
93
393
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
4.2
13.9
37
91
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
10.8
13.8
26
25
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
76.7
13.6
15
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
13.6
13
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
13.6
13
*
C53.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of cervix uteri
+∞
13.6
13
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
142.6
13.5
14
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.3
13.3
27
53
G04CA02
ATC
tamsulosin; oral
4.7
13.2
31
69
L02BG04
ATC
letrozole; oral
3.7
12.9
41
115
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
71.2
12.6
14
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.5
12
*
C530, 8085, 3
ICD-O-3
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
12.5
12
*
A79
ICPC
Malignancy NOS
+∞
12.5
12
*
XX2RW, ,
NOMESCO Finland
13.5
12.5
21
16
N87.1
ICD-10 Finland
Moderate cervical dysplasia
3.6
12.3
41
119
E89.4
ICD-10 Finland
Postprocedural ovarian failure
47.5
11.9
14
*
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.4
11.7
89
405
L02BA01
ATC
tamoxifen; oral
66.1
11.6
13
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
11.5
11
*
X77
ICPC
Malignant neopl genital female other
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
C531, 8085, 3
ICD-O-3
+∞
11.5
11
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
11.1
641
5664
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
3.5
10.8
37
109
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
3.1
10.8
47
161
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
10.7
71
304
Z51.0
ICD-10 Finland
Radiotherapy session
60.9
10.6
12
*
N82.0
ICD-10 Finland
Vesicovaginal fistula
60.9
10.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
60.9
10.6
12
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
111.6
10.4
11
*
JN5KS
NOMESCO Finland
Very extensive PET-MRI of body metabolism
+∞
10.4
10
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
10.4
10
*
8560/3-C53.9
ICD-O-3
Adenosquamous carcinoma of cervix uteri
+∞
10.4
10
*
C530, 8483, 3
ICD-O-3
+∞
10.4
10
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.4
10
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
10.4
10
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
19.1
10.3
15
8
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.4
10.2
17
13
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.6
10.1
59
237
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
40.7
10.0
12
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.8
9.8
22
47
B03XA02
ATC
darbepoetin alfa; parenteral
9.7
9.8
19
20
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
9.8
130
734
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
9.8
108
571
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
9.7
32
92
KA3EB
NOMESCO Finland
Antegrade pyelography
55.8
9.7
11
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
9.6
138
801
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
30.5
9.4
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.4
159
970
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
8380/3-C53.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of cervix uteri
+∞
9.4
9
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
22.0
9.4
13
6
Z70.8
ICD-10 Finland
Other sex counselling
9.7
9.3
18
19
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
9.2
234
1603
KBV10
NOMESCO Finland
Removal of stent from ureter
11.7
9.1
16
14
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
9.2
9.1
18
20
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
10.2
9.1
17
17
TJF80
NOMESCO Finland
Ostomy education
37.2
9.0
11
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
9.0
83
410
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.7
8.9
48
185
JN4CD
NOMESCO Finland
Very extensive body CT
10.9
8.8
16
15
B02AA02
ATC
tranexamic acid; systemic
1.8
8.7
155
958
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
50.6
8.7
10
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
50.6
8.7
10
*
LDW96
NOMESCO Finland
Other operation on cervix uteri
50.6
8.7
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
8.6
83
417
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
91.1
8.4
9
*
LDC10
NOMESCO Finland
Partial excision of cervix uteri
91.1
8.4
9
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
91.1
8.4
9
*
UJG02
NOMESCO Finland
Proctoscopy
4.5
8.4
20
45
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.3
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.3
8
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
8.3
8
*
18011, ,
ICD-8 Finland
+∞
8.3
8
*
ZXC00
NOMESCO Finland
Use of diathermy
10.9
8.3
15
14
JFB00
NOMESCO Finland
Partial resection of small intestine
9.6
8.3
16
17
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
33.8
8.1
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
8.1
69
330
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
7.9
78
396
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.2
7.6
30
97
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
18.6
7.6
11
6
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
7.6
32
108
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
25.3
7.6
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
80.9
7.4
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.4
261
1917
J01CE08
ATC
benzathine benzylpenicillin; parenteral
13.5
7.4
12
9
XX1AD
NOMESCO Finland
Other CT-examination
+∞
7.3
7
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
7.3
7
*
LAG10
NOMESCO Finland
Oophoropexy
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
7.3
7
*
1XC07, ,
NOMESCO Finland
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
7.3
7
*
C53.80
ICD-10 Finland
Overall malignant tumor of the cervix uteri without histology
+∞
7.3
7
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
8000/3-C53.9
ICD-O-3
Neoplasm, malignant of cervix uteri
+∞
7.3
7
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
WX892
NOMESCO Finland
Monitored bed care
2.5
7.3
47
199
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
5.9
7.3
19
33
O34.4
ICD-10 Finland
Maternal care for other abnormalities of cervix
15.9
7.2
11
7
WF099
NOMESCO Finland
Other radiotherapy
30.3
7.2
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
30.3
7.2
9
*
KC1GB
NOMESCO Finland
Cystography with X-ray
30.3
7.2
9
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
20.3
7.1
10
5
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
8.0
7.1
15
19
R31
ICD-10 Finland
Unspecified haematuria
2.5
7.1
44
183
R18
ICD-10 Finland
Ascites
8.9
7.1
14
16
JAH00
NOMESCO Finland
Laparotomy
4.3
7.0
18
43
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.0
268
1998
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
7.0
24
71
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
7.0
57
268
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.7
6.9
36
137
XKD00
NOMESCO Finland
Uroflowmetry
2.8
6.9
33
120
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
40.5
6.8
8
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.1
6.5
26
85
A46
ICD-10 Finland
Erysipelas
1.9
6.4
78
426
A06AH03
ATC
naloxegol; oral
14.5
6.4
10
7
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
0.4
6.3
27
680
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
6.3
21
61
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
11.2
6.3
11
10
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
18.2
6.3
9
5
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
18.2
6.3
9
5
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
6.3
6
*
18010, ,
ICD-8 Finland
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
LEE30
NOMESCO Finland
Closure of intestinovaginal fistula using graft or flap
+∞
6.3
6
*
ZX082, ,
NOMESCO Finland
+∞
6.3
6
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
6.3
6
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
12.7
6.1
10
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
12.7
6.1
10
8
A07DA03
ATC
loperamide; oral
3.0
6.1
26
89
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
178
411
5.46
75.55
2.3
1.5
—
—
—
0
0
391
1770
3.72
64.83
2.5
1.5
—
—
—
0
0
482
2708
3.47
52.65
3.5
2.4
—
—
estimate
—
0
0
34
25
14.24
36.73
1.0
1.2
—
—
—
0
0
352
1908
2.69
36.22
4.1
3.1
—
—
—
0
0
402
2341
2.67
35.53
6.4
3.7
34.95
36.63
g/l
6.45
381
2190
38
39
10.24
33.25
2.3
1.7
—
—
—
0
0
85
223
4.20
29.52
3.8
1.5
5.49
2.67
ug/l
1.04
66
158
428
2730
2.45
28.85
8.7
3.5
9.02
10.12
umol/l
1.28
414
2568
256
1317
2.48
27.67
2.9
1.8
—
—
—
0
0
471
3235
2.38
25.39
15.2
6.4
4.01
4.11
e9/l
0.37
430
2817
358
2197
2.28
25.19
10.0
11.2
1.14
1.17
inr
0.66
294
1823
299
1745
2.24
23.28
4.0
3.1
84.85
53.60
e6/l
0.26
245
1317
315
1942
2.13
20.72
5.3
2.0
2.36
2.35
mmol/l
0.23
300
1758
333
2149
2.04
18.85
4.9
3.7
162.02
97.32
e6/l
0.86
257
1410
254
1484
2.11
18.84
3.9
2.9
0.55
0.39
e6/l
0.63
199
1078
214
1216
2.09
16.75
2.9
2.6
10.43
8.93
e6/l
0.38
195
1109
545
4346
2.12
15.56
10.9
5.4
88.94
72.74
u/l
2.65
528
4074
527
4152
2.07
15.53
6.5
4.7
2997.44
4091.30
e6/l
0.22
18
50
156
811
2.19
15.20
3.7
2.7
5.09
4.19
e6/l
0.32
84
363
90
369
2.65
14.89
2.0
1.6
—
—
—
0
0
167
903
2.11
14.66
3.7
2.5
1.41
1.13
e6/l
0.35
93
451
105
484
2.37
13.52
3.1
2.8
—
—
—
0
0
440
3415
1.77
11.72
5.2
3.8
0.05
0.01
estimate
0.53
106
668
268
1816
1.77
11.46
5.2
3.8
0.00
0.00
estimate
0.50
104
652
323
2334
1.71
10.80
6.7
4.6
1.21
1.22
mmol/l
1.23
307
2134
361
2690
1.70
10.76
7.8
5.2
1.21
1.22
mmol/l
1.95
302
2332
117
618
2.07
10.68
5.3
5.9
—
—
—
0
0
85
397
2.30
10.55
6.1
2.2
215.38
221.81
u/l
0.32
85
380
429
3403
1.67
9.63
5.3
3.8
12.83
4.22
estimate
0.29
108
691
424
3357
1.66
9.55
5.3
3.8
0.00
0.00
estimate
-0.00
108
683
411
3235
1.65
9.41
5.5
3.9
6.44
6.43
mmol/l
0.06
393
2977
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
88
3.52
8.86
2.9
2.7
0.34
0.40
iu/ml
0.45
18
59
254
1805
1.64
8.53
4.4
2.3
52.13
56.54
u/l
1.36
243
1667
22
56
4.02
7.93
1.2
1.3
—
—
—
0
0
90
483
1.99
7.79
6.7
5.8
12.61
11.97
kpa
0.59
85
466
90
483
1.99
7.79
6.7
5.8
5.12
5.07
kpa
0.25
85
467
13
11
12.01
7.60
2.7
1.3
13.90
13.62
ug/l
0.06
13
11
89
482
1.97
7.51
6.7
5.8
1.27
1.15
mmol/l
0.12
72
388
543
5990
0.59
7.39
4.2
4.7
4.90
4.79
mmol/l
1.88
520
5672
83
448
1.97
7.06
4.8
2.9
1.38
2.04
mmol/l
0.74
77
387
34
126
2.78
6.86
1.4
1.6
—
—
—
0
0
543
5968
0.61
6.77
4.1
4.6
1.54
1.56
mmol/l
0.33
520
5625
38
151
2.60
6.71
1.6
1.2
—
—
—
0
0
54
258
2.18
6.36
1.8
1.6
—
—
—
0
0
33
126
2.70
6.31
1.8
1.6
2.47
1.12
ug/l
0.60
33
111
9
5
18.20
6.27
1.2
1.2
—
—
—
0
0
328
2598
1.49
6.27
5.3
3.6
0.01
0.03
estimate
0.66
90
553
507
5616
0.65
5.74
5.1
5.5
37.89
38.06
mmol/mol
0.17
490
5315
558
6053
0.62
5.70
4.5
5.2
2.88
2.81
mmol/l
1.33
533
5712
512
5656
0.65
5.66
3.6
3.9
1.32
1.22
mmol/l
2.83
489
5274
159
1104
1.57
5.53
4.1
2.0
2.48
2.43
mmol/l
5.17
148
984
195
2576
0.66
5.48
1.9
1.8
1.42
1.31
mmol/l
1.33
163
2248
127
858
1.59
4.93
2.7
2.2
2.21
2.43
g/l
3.07
115
789
260
2040
1.44
4.89
4.2
2.7
31.78
27.09
u/l
0.92
250
1941
203
1537
1.45
4.57
4.5
4.0
1.02
2.00
kg/l
0.50
143
1025
67
391
1.79
4.51
3.9
2.3
1.22
1.23
mmol/l
0.55
61
321
22
82
2.74
4.45
1.3
1.3
—
—
—
0
0
116
788
1.57
4.39
2.1
1.8
—
—
—
0
0
78
481
1.70
4.34
2.0
2.1
393.50
6318.07
u/l
4.14
33
210
11
20
5.57
4.30
1.6
1.2
—
—
—
0
0
11
20
5.57
4.30
1.6
1.2
—
—
—
0
0
31
140
2.27
4.24
1.5
1.8
3.72
3.57
g/l
0.18
31
130
638
5981
1.71
4.22
24.3
13.1
139.28
139.66
mmol/l
3.53
628
5844
638
5988
1.70
4.11
24.4
13.1
3.91
3.92
mmol/l
0.18
629
5837
639
6001
1.70
4.09
22.9
11.8
28.57
19.31
mg/l
9.06
567
4753
10
19
5.32
3.84
1.4
1.1
17514.00
438990.88
e6/l
—
5
8
65
398
1.70
3.73
7.2
4.9
1.35
1.24
mmol/l
0.43
65
389
67
417
1.67
3.62
2.7
2.2
65.79
73.00
ml/min/173m2
0.79
34
174
108
755
1.51
3.58
3.0
2.3
20.57
23.11
%
1.04
101
700
102
714
1.50
3.36
2.1
1.7
30.71
29.27
s
0.45
102
690
85
577
1.54
3.23
2.1
1.7
—
—
—
0
0
605
5670
1.48
3.22
21.8
10.5
84.15
85.05
ml/min/173m2
0.45
556
5138
129
955
1.43
3.19
2.9
2.2
11.49
13.92
umol/l
3.14
119
889
7
11
6.41
3.19
1.9
1.9
1.57
0.64
%
—
7
11
7
13
5.43
2.87
1.0
1.1
211.43
1036.46
u/l
—
7
13
11
34
3.27
2.73
1.3
1.1
—
—
—
0
0
89
633
1.46
2.73
1.3
1.3
46.14
23.66
iu/l
4.19
72
550
33
183
1.84
2.70
1.9
1.7
—
—
—
0
0
229
1901
1.30
2.69
4.7
3.1
0.00
0.10
estimate
0.56
92
552
79
560
1.46
2.47
2.2
1.8
—
—
—
0
0
23
118
1.98
2.38
2.3
3.6
33.79
24.48
mg/l
0.49
13
82
7
17
4.15
2.36
2.3
4.2
0.57
0.82
index
—
7
17
30
170
1.80
2.32
1.3
1.3
0.39
0.43
nmol/l
0.12
21
150
56
375
1.54
2.31
1.7
1.5
—
—
—
0
0
6
13
4.64
2.27
2.2
1.1
—
—
—
0
0
6
13
4.64
2.27
2.2
1.1
—
—
—
0
0
7
18
3.92
2.25
1.0
2.8
115.71
102.56
%
—
7
18
29
168
1.76
2.11
1.3
1.2
—
—
—
0
0
550
5789
0.77
2.09
4.7
4.6
5.82
5.73
mmol/l
0.73
523
5400
39
246
1.62
2.09
2.5
2.1
1.46
1.17
%
0.86
39
246
29
169
1.75
2.07
1.7
1.7
—
—
—
0
0
39
248
1.61
2.03
2.5
2.1
0.60
0.61
%
0.14
39
248
30
180
1.70
1.95
1.6
1.4
282.76
323.96
ug/g
0.51
17
100
44
292
1.54
1.92
3.0
2.4
126.20
129.61
g/l
0.49
44
284
36
549
0.64
1.90
1.3
1.3
409.83
206.37
u/ml
0.43
31
515
28
451
0.61
1.87
1.6
1.4
—
—
—
0
0
170
1418
1.26
1.86
1.7
1.6
2.11
0.91
mg/l
1.46
135
1058
39
254
1.57
1.85
1.7
1.5
—
—
—
0
0
18
326
0.54
1.85
1.7
1.7
2.08
2.74
mg/l
0.77
11
224
25
413
0.59
1.85
1.6
1.5
57.17
60.34
ug/l
0.12
19
337
566
5917
0.78
1.84
6.4
6.1
1.82
1.79
mu/l
0.15
536
5617
34
215
1.61
1.83
4.3
2.7
25.62
25.40
mmol/l
0.13
34
209
29
456
0.62
1.76
1.4
1.3
—
36.43
—
0
33
53
374
1.45
1.75
2.1
2.2
3.10
5.87
ug/l
2.16
48
328
5
13
3.87
1.71
1.8
1.2
9.80
11.54
u/l
—
5
13
73
551
1.36
1.66
2.9
2.2
40.43
39.27
u/l
0.04
65
460
39
264
1.51
1.59
5.6
3.1
5.05
5.18
kpa
0.59
39
252
22
129
1.73
1.58
2.9
3.3
1.00
1.04
index
0.02
13
52
18
100
1.82
1.54
1.8
3.1
—
—
—
0
0
24
378
0.62
1.50
1.5
1.5
—
—
—
0
0
50
679
0.72
1.48
1.4
1.6
1172.38
1011.32
mu/l
0.49
35
550
17
94
1.83
1.48
1.2
1.4
—
—
—
0
0
17
94
1.83
1.48
1.2
1.4
—
—
—
0
0
13
66
1.99
1.44
1.7
1.2
—
—
—
0
0
13
67
1.96
1.39
1.7
1.2
—
—
—
0
0
13
67
1.96
1.39
1.7
1.2
—
—
—
0
0
25
381
0.64
1.37
1.4
1.5
1.19
1.17
ratio
0.03
16
235
25
381
0.64
1.37
1.4
1.5
1.12
1.11
ratio
0.02
16
234
25
381
0.64
1.37
1.4
1.5
0.94
0.99
ratio
0.19
16
234
77
605
1.31
1.37
2.4
2.1
5.80
4.69
umol/l
0.49
66
505
226
2000
1.19
1.36
3.9
3.3
20.85
85.76
ng/l
0.96
138
1158
49
655
0.73
1.34
4.1
4.5
31.69
32.97
%
0.39
42
443
650
6331
1.35
1.31
28.2
14.3
72.72
68.45
umol/l
2.67
642
6245
6
24
2.51
1.30
2.2
1.5
7.57
8.34
ug/l
—
6
24
12
62
1.95
1.28
1.7
1.2
—
—
—
0
0
12
63
1.92
1.23
1.7
1.2
—
—
—
0
0
12
63
1.92
1.23
1.7
1.2
—
—
—
0
0
509
5314
0.85
1.16
5.7
5.0
14.74
14.49
pmol/l
1.56
481
4997
0
34
0.00
1.16
0.0
1.9
—
—
—
0
0
8
39
2.06
1.15
3.0
1.8
—
—
—
0
0
32
227
1.43
1.10
4.8
2.9
1.74
1.75
mmol/l
0.01
22
158
20
302
0.65
1.08
2.0
1.7
1.82
8.69
u/ml
—
6
73
7
32
2.20
1.08
3.7
2.9
495.43
942.94
u/ml
—
7
32
22
324
0.67
1.06
1.3
1.6
—
—
—
0
0
15
239
0.62
1.04
1.2
1.5
66.25
57.16
ug/l
0.43
15
239
141
1609
0.85
1.02
1.6
1.7
—
—
—
0
0
17
109
1.57
0.94
1.4
1.4
—
—
—
0
0
8
42
1.92
0.88
1.4
1.5
1632.63
766.98
mg
—
8
42
11
64
1.73
0.86
1.2
1.3
—
45.22
—
0
6
10
57
1.77
0.84
2.3
2.1
1.21
1.19
mmol/l
—
10
57
10
57
1.77
0.84
2.3
2.1
102.70
106.16
mmol/l
—
10
57
8
46
1.75
0.82
1.5
1.4
—
—
—
0
0
28
206
1.37
0.82
1.3
1.2
—
—
—
0
0
538
5200
1.15
0.82
27.3
14.2
13.89
13.42
%
9.80
531
5118
6
32
1.88
0.82
1.0
1.4
—
476.67
—
0
6
157
1408
1.15
0.79
2.5
2.8
2705.23
1023.00
ng/l
1.12
137
1166
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
56
676
0.81
0.76
1.6
1.2
150.82
134.19
u/ml
0.14
16
285
54
653
0.81
0.75
1.6
1.7
3.64
3.45
mmol/l
0.57
36
458
160
1764
0.88
0.73
1.4
1.3
0.58
1.78
u/ml
2.44
58
504
14
206
0.67
0.72
1.6
1.5
0.01
0.45
iu/ml
—
6
28
22
297
0.73
0.71
1.1
1.2
0.95
0.87
g/l
0.91
22
297
15
101
1.50
0.70
1.1
1.2
—
—
—
0
0
12
181
0.66
0.70
1.4
1.2
473.25
435.45
mg/l
0.12
12
172
9
58
1.56
0.70
1.7
1.2
158.89
119.90
pmol/l
—
9
58
180
1644
1.13
0.69
2.6
2.3
3.19
2.68
mg/l
1.91
156
1429
13
85
1.54
0.69
1.8
1.6
—
—
—
0
0
27
205
1.33
0.68
1.3
1.2
—
—
—
0
0
37
295
1.27
0.66
1.5
1.3
235.06
242.86
miu/ml
0.05
18
152
650
6589
0.82
0.65
34.5
18.3
4.26
4.44
e12/l
17.76
641
6450
40
324
1.25
0.64
2.0
2.0
7.78
6.37
iu/ml
0.11
18
69
22
291
0.75
0.63
1.1
1.1
1.63
1.62
g/l
0.07
22
291
650
6585
0.83
0.60
34.6
18.3
257.81
264.45
e9/l
1.89
643
6466
640
6297
1.18
0.60
15.1
9.4
24.36
22.92
u/l
1.12
628
6116
8
52
1.54
0.59
1.0
2.0
7.25
77.44
u/ml
—
8
52
9
61
1.48
0.54
1.2
1.3
—
—
—
0
0
36
435
0.82
0.53
1.3
1.5
—
—
—
0
0
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
431
4452
0.92
0.51
3.5
3.6
—
—
—
0
0
12
168
0.71
0.51
1.3
1.2
3.36
3.69
mmol/l
1.52
12
161
115
1044
1.12
0.51
1.8
2.0
—
—
—
0
0
33
270
1.23
0.51
1.3
1.9
—
—
—
0
0
9
65
1.39
0.50
2.1
1.4
—
—
—
0
0
35
421
0.82
0.50
1.1
1.1
—
—
—
0
0
20
257
0.77
0.50
1.7
1.6
0.38
0.26
mg/l
—
9
104
31
377
0.81
0.49
1.5
1.7
295.31
312.66
mu/l
0.15
26
332
127
1162
1.11
0.49
1.9
2.1
—
—
—
0
0
75
842
0.88
0.47
1.6
1.8
3.19
3.24
ratio
0.16
55
647
5
82
0.61
0.46
1.4
1.1
—
—
—
0
0
10
141
0.71
0.45
1.3
1.3
—
—
—
0
0
468
4555
1.08
0.43
4.4
4.4
15.78
10.85
mm/h
7.33
447
4297
8
57
1.41
0.42
1.0
1.0
199.50
195.23
mg/l
—
8
52
0
15
0.00
0.41
0.0
1.5
—
5.73
—
0
15
0
15
0.00
0.41
0.0
1.1
—
104.93
—
0
15
15
114
1.32
0.41
1.4
1.4
—
—
—
0
0
16
205
0.78
0.40
1.4
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
5.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
45
391
1.16
0.39
1.2
1.4
—
—
—
0
0
15
115
1.31
0.39
1.0
1.1
2.13
3.02
eliau/ml
—
7
56
13
168
0.77
0.36
1.3
1.6
—
—
—
0
0
143
1341
1.08
0.35
2.8
2.1
318.67
309.01
umol/l
0.52
126
1182
27
228
1.19
0.34
2.0
1.8
0.23
0.23
g/l
0.06
27
220
6
46
1.31
0.33
1.2
1.3
—
—
—
0
0
6
46
1.31
0.33
1.3
1.1
—
—
—
0
0
28
238
1.18
0.33
2.0
1.7
1.27
1.19
g/l
0.72
28
227
15
119
1.27
0.32
2.1
2.0
4.05
5.08
mmol/24h
0.91
15
105
7
52
1.35
0.31
1.4
1.3
—
—
—
0
0
182
1732
1.07
0.31
2.4
2.1
164.34
147.32
u/l
0.19
175
1649
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
24
279
0.86
0.27
1.7
1.8
—
—
—
0
0
21
246
0.85
0.26
1.1
1.3
29.54
9.38
u/ml
—
5
45
10
77
1.30
0.26
1.3
1.3
—
—
—
0
0
14
115
1.22
0.23
1.0
1.1
—
—
—
0
0
307
2993
1.05
0.22
2.8
2.5
73.89
77.89
nmol/l
1.83
287
2754
100
946
1.07
0.21
1.7
1.7
1099.71
1183.83
nmol/l
0.41
81
725
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
175
1685
1.05
0.21
1.7
1.6
18.19
20.98
nmol/l
2.05
156
1462
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
1.19
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
5.91
—
0
8
0
13
0.00
0.21
0.0
1.1
—
78.31
—
0
13
533
5270
1.05
0.19
27.8
15.5
331.22
331.23
g/l
0.01
526
5235
166
1716
0.96
0.17
4.9
3.9
26.35
7.65
mg/mmol
1.83
115
1007
65
690
0.94
0.17
1.7
1.6
1.45
1.33
%
1.11
55
619
5
66
0.76
0.17
1.2
1.1
1.30
1.46
g/l
—
5
61
12
101
1.19
0.16
1.2
1.4
—
—
—
0
0
6
76
0.79
0.15
1.7
1.5
—
—
—
0
0
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
10
118
0.85
0.14
1.4
1.8
—
—
—
0
0
10
85
1.18
0.12
1.2
1.4
—
—
—
0
0
11
126
0.87
0.11
1.2
1.2
—
69.42
—
0
5
10
86
1.17
0.11
1.3
1.3
778.30
396.63
pmol/l
—
10
76
23
249
0.92
0.10
1.5
2.1
3.41
25.16
iu/l
0.52
11
111
183
1867
0.97
0.10
3.5
3.3
6.37
6.91
mmol/l
1.19
159
1603
5
44
1.14
0.10
1.4
1.3
74.40
72.80
umol/l
—
5
44
14
155
0.90
0.09
1.5
2.2
3.96
4.64
umol/l
—
8
113
11
97
1.14
0.09
1.2
1.3
—
—
—
0
0
12
107
1.12
0.08
1.1
1.3
—
—
—
0
0
6
58
1.03
0.08
1.0
1.3
—
—
—
0
0
6
58
1.03
0.08
1.0
1.3
—
—
—
0
0
7
64
1.09
0.08
1.1
1.4
—
—
—
0
0
6
70
0.86
0.07
1.2
1.1
—
—
—
0
0
6
75
0.80
0.07
1.5
1.4
—
—
—
0
0
419
4220
0.98
0.07
3.7
3.0
57.30
34.82
u/l
1.84
402
4003
8
93
0.86
0.06
1.1
1.4
—
—
—
0
0
8
94
0.85
0.06
7.8
6.6
433.00
371.77
umol/l
—
8
82
123
1254
0.98
0.06
1.6
1.7
68182298.00
30798223.50
pmol/l
0.23
110
1078
143
1455
0.98
0.06
1.4
1.4
45.04
30.13
iu/ml
0.35
47
436
33
316
1.05
0.05
1.3
1.3
0.27
0.61
u/ml
—
7
23
357
3545
1.01
0.05
3.1
3.2
158.06
70.69
ug/l
5.85
342
3366
263
2606
1.01
0.05
2.1
2.1
91.95
98.57
pmol/l
1.60
167
1301
139
1371
1.02
0.04
1.2
1.3
13.15
11.46
u/ml
0.09
63
564
21
220
0.95
0.03
1.5
1.3
—
—
—
0
0
10
92
1.09
0.03
1.8
1.5
—
—
—
0
0
65
656
0.99
0.00
1.4
1.8
—
—
—
0
0
82
814
1.01
0.00
1.5
1.9
—
—
—
0
0
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
104
1037
1.00
0.00
5.0
3.6
226.14
269.75
ng/l
0.13
71
673
6
68
0.88
0.00
1.0
1.1
—
70.43
—
0
7
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
8.02
—
0
9
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
3.8
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.43
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
2.48
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_UTERI – Malignant neoplasm of cervix uteri
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).